Edition:
United States

PerkinElmer Inc (PKI)

PKI on New York Consolidated

68.17USD
22 Sep 2017
Change (% chg)

$-0.03 (-0.04%)
Prev Close
$68.20
Open
$68.14
Day's High
$68.33
Day's Low
$67.80
Volume
378,916
Avg. Vol
614,340
52-wk High
$70.16
52-wk Low
$45.35

Latest Key Developments (Source: Significant Developments)

PerkinElmer launches QSight210 MD system for clinical laboratories
Friday, 8 Sep 2017 08:15am EDT 

Sept 8 (Reuters) - Perkinelmer Inc :PerkinElmer Inc - launches QSight210 MD system for clinical laboratories.  Full Article

PerkinElmer enters into 364-day unsecured term loan facility
Tuesday, 15 Aug 2017 04:26pm EDT 

Aug 15 (Reuters) - PerkinElmer Inc ::PerkinElmer Inc - ‍on August 11, entered into a 364-day unsecured term loan facility in principal amount of $200 million - SEC filing​.PerkinElmer Inc - ‍term loans under facility are available from effective date until earliest of 3:00 P.M. New York City time on December 31, 2017​.PerkinElmer Inc - ‍on August 11, 2017, company entered into an amendment no. 1 to its existing credit agreement, dated August 11, 2016​.PerkinElmer Inc - ‍amendment amends revolving credit agreement to remove foreign currency sublimit under facility​.PerkinElmer Inc - ‍amendment to amend financial covenants to allow for higher consolidated leverage ratio through fiscal quarter ending July 1, 2018​.  Full Article

BRIEF-PerkinElmer launches clinical whole genome sequencing services
Friday, 4 Aug 2017 09:24am EDT 

Corrects thoughtout to PerkinElmer from Perkinelmer:PerkinElmer launches clinical whole genome sequencing services.Announced launch of PerkinElmer genetics' clinical genomics services.  Full Article

PerkinElmer reports Q2 GAAP EPS from continuing operations $0.57
Thursday, 3 Aug 2017 04:15pm EDT 

Aug 3 (Reuters) - PerkinElmer Inc ::Q2 GAAP earnings per share from continuing operations $0.57; Q2 adjusted earnings per share $0.67; Q2 GAAP revenue $547.0 million versus $536.2 million.Based on overall performance for H1, remain on track to deliver FY financial commitments.Sees FY GAAP earnings per share from continuing operations $2.23-$2.31; sees FY adjusted earnings per share $2.84-$2.92.Q2 earnings per share view $0.67, revenue view $554.0 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $2.86 -- Thomson Reuters I/B/E/S.  Full Article

Perkinelmer launches clinical whole genome sequencing services
Thursday, 3 Aug 2017 01:14pm EDT 

Aug 3 (Reuters) - Perkinelmer Inc :Perkinelmer launches clinical whole genome sequencing services.Announced launch of perkinelmer genetics' clinical genomics services.  Full Article

PerkinElmer to acquire Euroimmun for about $1.3 bln
Monday, 19 Jun 2017 03:00am EDT 

June 19 (Reuters) - PerkinElmer Inc ::PerkinElmer to acquire Euroimmun for approximately $1.3 billion.Agreement provides that perkinElmer will acquire up to a 100% stake in Euroimmun.Total purchase price of transaction based on all outstanding shares being acquired will be approximately $1.3 billion in cash.PerkinElmer Inc - acquisition is expected to be accretive to perkinelmer's 2018 non-gaap earnings per share results by approximately $0.28 to $0.30.Says PerkinElmer is reaffirming its 2017 revenue and earnings per share guidance.  Full Article

PerkinElmer reports Q1 GAAP earnings per share of $0.33
Thursday, 4 May 2017 04:15pm EDT 

May 4 (Reuters) - PerkinElmer Inc :PerkinElmer Inc says raises full year revenue and earnings per share guidance.Quarterly GAAP revenue of $514 million, an increase of 3%.Quarterly organic revenue increased 4%.Says Q1 GAAP earnings per share from continuing operations of $0.33, as compared to $0.38 in q1 of 2016.Quarterly adjusted earnings per share of $0.55.Q1 earnings per share view $0.54, revenue view $506.0 million -- Thomson Reuters I/B/E/S.Says for 2017, forecasts GAAP earnings per share from continuing operations in range of $2.16 to $2.26 .FY2017 earnings per share view $2.82 -- Thomson Reuters I/B/E/S.Sees 2017 adjusted earnings per share of $2.80 to $2.90.  Full Article

Perkinelmer says qtrly GAAP revenue of $514 million
Thursday, 4 May 2017 04:15pm EDT 

May 4 (Reuters) - Perkinelmer Inc :Perkinelmer Inc says raises full year revenue and earnings per share guidance.Qtrly GAAP revenue of $514 million, an increase of 3%.Qtrly organic revenue increased 4%.Perkinelmer inc says Q1 GAAP earnings per share from continuing operations of $0.33, as compared to $0.38 in Q1 of 2016.Qtrly adjusted earnings per share of $0.55.Perkinelmer Inc says for 2017, now forecasts gaap earnings per share from continuing operations in range of $2.16 to $2.26 and on a non-gaap basis.FY2017 earnings per share view $2.82 -- Thomson Reuters I/B/E/S.Q1 earnings per share view $0.54, revenue view $506.0 million -- Thomson Reuters I/B/E/S.  Full Article

PerkinElmer Inc says Chairman and CEO Robert Friel's total compensation for 2016 was $9.5 mln
Wednesday, 8 Mar 2017 08:29am EST 

PerkinElmer Inc :PerkinElmer Inc - Chairman and Chief Executive Officer Robert Friel's total compensation for 2016 was $9.5 million versus $8.5 million in 2015 - SEC filing.  Full Article

PerkinElmer Q4 GAAP EPS $0.57 from continuing operations
Thursday, 2 Feb 2017 04:24pm EST 

PerkinElmer Inc : Q4 revenue for discovery & analytical solutions $409.9 million versus $418.2 million . Q4 GAAP earnings per share $0.57 from continuing operations . Q4 adjusted earnings per share $0.83 from continuing operations . Sees FY 2017 adjusted non-gaap earnings per share $2.75 to $2.85 . Sees FY 2017 gaap earnings per share $2.06 to $2.16 from continuing operations . Qtrly revenue was $566.8 million versus $569.9 million in comparable prior period of 2015 .Q4 earnings per share view $0.86, revenue view $609.7 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-PerkinElmer ‍announced upcoming retirement of Andy Wilson CFO

* PerkinElmer Inc - ‍Announced upcoming retirement of Andy Wilson, senior vice president and chief financial officer​